Meeting
2021 Genitourinary Cancers Symposium
Analysis of plasma KIM-1 as a biomarker for recurrence risk after resection for localized renal cell carcinoma.
Authors
Wenxin Xu
Dana-Farber Cancer Institute, Boston, MA
Wenxin Xu , Brian Halbert , Naomi B. Haas , Keith Flaherty , Robert Guy Uzzo , Janice P. Dutcher , Robert S. DiPaola , Venkata Sabbisetti , Rupal Satish Bhatt , Maneka Puligandla
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 342)
DOI
10.1200/JCO.2021.39.6_suppl.342
Abstract #
342
Poster Bd #
Online Only
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2019 ASCO Annual Meeting
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
First Author: Daniel Vargas Almeida
Poster
2018 Genitourinary Cancers Symposium
Association of age and sex with mortality following adjuvant therapy for renal cell cancer (RCC): Subgroup analysis of the ASSURE (E2805) trial.
First Author: Ronac Mamtani
Poster
2020 Genitourinary Cancers Symposium
Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.
First Author: Rabbia Siddiqi
Poster
2018 ASCO Annual Meeting
Disease-free survival in patients at highest risk of recurrent renal cell carcinoma in S-TRAC.
First Author: Alain Ravaud